Logo | Name | Σ | ||
---|---|---|---|---|
ENGIE ENGIE is a global reference in low-carbon energy and services. With its 97,000 employees, clients, partners and stakeholders, the Group strives every day to accelerate the transition towards a carbon-neutral economy, through reduced energy consumption and more environmentally friendly solutions. Inspired by its purpose statement, ENGIE reconciles economic performance with a positive impact on people and the planet, building on its key businesses (gas, renewable energy, services) to offer competitive solutions to its clients. We are a united group, committed to inclusiveness and diversity, where everyone can forge their own career path , improve on their skills, and continually enhance … | 3541 | 2891 | 507 | |
Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: Pharmaceutical | 391 | 335 | 58 | |
Kurma Partners Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech Sectors: Startup accelerator & VC | 141 | 91 | 36 | |
Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: Bank | 12301 | 9342 | 1576 | |
Sofinnova Partners Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential … | 376 | 193 | 201 | |
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3486 | 2601 | 833 | |
Danone Danone is a leading global food and beverage company operating in three health-focused, fast-growing, and on-trend Categories: Essential Dairy & Plant-Based products, Waters, and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices while committing to achieve measurable nutritional, social, societal, and environment impact. Danone has defined its “Renew” strategy to restore growth, competitiveness, and value creation for the long-term. With almost 90,000 employees, and products sold in over 120 markets, Danone generated €27.6 billion in sales in 2023. Danone’s … | 2138 | 1751 | 313 | |
Seventure Partners We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences. Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the Planet. With €950m net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe investing since 1997 in innovative businesses with high growth potential in 2 main areas: Life sciences (Biotech, Health & digital Health, Nutrition, Foodtech, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Wellness ...) with a specific interest for … Sectors: Startup accelerator & VC | 292 | 174 | 95 | |
Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: French Cluster Public business cluster | 629 | 381 | 382 | |
Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: Biotechnology Pharmaceutical | 806 | 622 | 70 | |
Syneos Health Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment. Clinical Trials and Biopharmaceutical Product Lifecycle Management Sectors: Pharmaceutical | 140 | 124 | 20 | |
Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: Pharmaceutical | 598 | 332 | 75 | |
Novo Nordisk Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: Pharmaceutical | 1360 | 1110 | 144 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1761 | 1567 | 123 | |
NHS England We lead and support the NHS in England to deliver improved care for patients. We work with NHS Improvement to act as a single organisation to better support the NHS to deliver improved care for patients: https://www.england.nhs.uk/comment-policy NHS England is increasing transparency in the NHS and improving services for patients. We work with NHS staff, patients, stakeholders and the public to improve the health outcomes for people in England. We are responsible for the stewardship of £99 billion of public funds to provide comprehensive health and care services available to all, where there is clinical need and regardless of an … Sectors: Insurance | 2036 | 1725 | 93 | |
Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: Biotechnology Pharmaceutical | 702 | 551 | 84 | |
McKinsey & Company We accelerate sustainable and inclusive growth. McKinsey & Company is a global management consulting firm. We are the trusted advisor to the world's leading businesses, governments, and institutions. We work with leading organizations across the private, public and social sectors. Our scale, scope, and knowledge allow us to address problems that no one else can. We have deep functional and industry expertise as well as breadth of geographical reach. We are passionate about taking on immense challenges that matter to our clients and, often, to the world. We work with our clients as we do with our colleagues. We build … Sectors: Consulting | 4750 | 4039 | 673 | |
IOT Solutions World Congress Disruptive Technologies for Industry📡 #IOTSWC25 | 📆 13-15 MAY 2025 | 📍 Fira Gran Via Barcelona Disruptive Technologies for Industry Challenges 📡 #IoT Solutions World Congress | Let's look forward to #IOTSWC25, May 13-15, 2025 📆 | 📍 Barcelona IoT, Industrial Internet, IIoT, Bigdata, Cloud, Cibersecurity, Cloud, Internet, Technology, Digitalization, and Industries | 807 | 463 | 299 | |
Illumina For Startups Illumina for Startups supporting genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include Startups Grants for founders to work with Illumina sites to run proof-of-concept sequencing experiments. For more information visit https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK. Illumina Accelerator … Sectors: Biotechnology Startup accelerator & VC | 917 | 456 | 155 | |
Dreamit Ventures Dreamit Ventures invests in transformative early-stage cybersecurity startups Dreamit Ventures invests in transformative early-stage cybersecurity startups with revenue or pilots that are ready to scale. Our deep expertise and extensive network of partners ignite revenue growth and open doors to smart capital. Since its founding in 2008, Dreamit has invested in 300+ companies across four funds, including Oort (acquired by Cisco), LevelUp (acquired by GrubHub), Trendkite (acquired by Cision), SeatGeek, HouseParty (acquired by Epic Games), Adaptly (acquired by Accenture), Wellth, Biomeme, Tissue Analytics (acquired by Net Health), Redox, Eko Devices, NestEgg, Cylera and Elevate. Startups, Venture Capital, Mentorship, Investment, cybersecurity, … Sectors: Startup accelerator & VC | 484 | 206 | 306 | |
Allia Ltd Allia is a not-for-profit dedicated to delivering positive impact for people, planet and place. Allia is a not-for-profit dedicated to helping entrepreneurs and ventures to thrive, delivering positive impact for people, planet and place. We have locations in Cambridge, London and Peterborough – where we offer targeted support to those businesses that focus on addressing challenges for society and the environment. Our Future Business Centres offer flexible workspace, co-working and a community for those creating change. Our venture support programmes help entrepreneurs, ventures and small businesses to explore their ideas, start-up, grow and thrive. We also work on delivering impact … | 206 | 85 | 101 | |
Cambridge Enterprise Helping to commercialise research from the University of Cambridge for the benefit of society worldwide. Cambridge Enterprise is the commercialisation arm of the University of Cambridge. At Cambridge Enterprise, we help University of Cambridge members create beneficial impact from their research and expertise that can change the world, through academic consultancy, intellectual property management, development and licensing, venture building, venture funding and convening and connecting the wider Cambridge innovation ecosystem. Our success is measured in the success of our University partners as they bring their work to market, be it ground-breaking stem cell research, critical suspension technology used in Formula … Sectors: Startup accelerator & VC | 238 | 127 | 89 | |
Aviva Investors Bringing it all together for today's investor Welcome to Aviva Investors. The global asset manager that chooses integration. The future is full of questions. Only by working closely with our clients can we find the answers. That’s why we integrate our whole business around our clients – their goals, their values and the experience they have when they work with us. That’s why we start by listening closely and understanding their investment aspirations and concerns – from low prospective investment returns, to highly correlated asset prices; from the prospect of rising global interest rates, to the challenges and opportunities of … Sectors: Insurance | 2226 | 1302 | 284 | |
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3790 | 2621 | 203 | |
Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1621 | 945 | 333 | |
Allen & Overy On May 1, 2024, Allen & Overy and Shearman & Sterling merged to become A&O Shearman. Follow us for more information @A&OShearman Content on this page is general information only and not advice https://www.aoshearman.com/en/legal-notices Banking & Finance, Antitrust, Corporate, International Capital Markets, Employment & Benefits, Environment, Insurance, IP/Litigation, Islamic Finance, M&A /Private Equity, Outsourcing, Partnerships, Projects, Real Estate, Regulatory, Restructuring, Tax, M&A, Public law, and Financial Services Regulation & Investigations Sectors: Law Practice | 565 | 493 | 38 | |
AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 941 | 772 | 130 | |
UK Research and Innovation Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves … Sectors: Public business cluster | 4041 | 2861 | 695 | |
Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: Biotechnology Pharmaceutical | 1487 | 870 | 336 | |
Intuitive A global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. Robotics, Medical Devices, minimally invasive surgery, robotic-assisted surgery, robotic surgery, lung biopsy, and endoluminal system Sectors: Medical Device | 216 | 137 | 39 | |
Nasdaq At Nasdaq, our purpose is to advance economic progress for all. At Nasdaq, our purpose is to advance economic progress for all. We power stronger economies, create more equitable opportunities, and contribute to a more sustainable world to help our communities, clients, employees, and people of all backgrounds reach their full potential. Meet the #NasdaqFam and learn about our purpose, culture and careers here: https://www.nasdaq.com/about/careers Technology Solutions, Financial Markets, Global Trading, Equities, Market Technology, Market Services, Fixed Income, Derivatives, Corporate Solutions, Global Index Services, Listing Services, and Nasdaq MarketSite Sectors: Finance | 6655 | 4968 | 1162 | |
Slush The most founder-focused event on Earth. Slush 2024 is on Nov 20–21. Tickets out now: slush.org/tickets The most founder-focused event on Earth is taking place on Nov 20–21 in Helsinki, Finland. Welcome to Slush 2024: Metamorphosis. Tickets out now: slush.org/tickets Slush is a not-for-profit on a mission to help and create founders to change the world. Founded in 2008, Slush annually hosts the world's leading startup event in Helsinki, Finland. Slush is run by students and recent graduates. International, High-growth, Startups, and Investors | 2546 | 1749 | 592 | |
PwC At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 152 countries with over 327,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Content on this page has been prepared for general information only and is not intended to be relied upon as accounting, tax or professional advice. … Sectors: Consulting, audit | 5375 | 4730 | 300 | |
PepsiCo PepsiCo is a playground for curious people. We invite thinkers, doers, and changemakers to champion innovation, take calculated risks, and challenge the status quo. From executives to team members on the front lines, we’re excited about the future. We take chances. Together, we dare to make the world a better place. Our associates are the magic ingredient. Each of them plays an integral role in helping create deep connections between people and our products. Think about your last group celebration: Chances are, one of our iconic brands was by your side. At PepsiCo, you’re invited to be a part of … Sectors: Food | 2122 | 1892 | 51 | |
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2108 | 1856 | 189 | |
Financial Times About the Financial Times The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community. Learn more about the FT, including announcements and career opportunities, at aboutus.ft.com. Subscribe at subs.ft.com. One of the world’s leading business news organisations Sectors: Media | 10647 | 9398 | 476 | |
Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: Biotechnology | 699 | 485 | 49 | |
Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4533 | 2894 | 644 | |
UK Export Finance We help UK companies of all sizes win contracts, fulfil orders and get paid. UK Export Finance is the UK’s export credit agency and a government department, working alongside the Department for Business and Trade as an integral part of its strategy and operations. Our mission is to advance prosperity by ensuring no viable UK export fails for lack of finance or insurance, doing that sustainably and at no net cost to the taxpayer. We help UK companies of all sizes and in all sectors win, fulfil and get paid for export contracts. Export finance and insurance Sectors: National and local authorities | 3582 | 2700 | 447 | |
Boehringer Ingelheim Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 1886 | 1267 | 258 | |
KPMG KPMG is a global network of professional firms providing Audit, Tax and Advisory services. We have 273,000 outstanding professionals working together to deliver value in 143 countries and territories. With a worldwide presence, KPMG continues to build on our successes thanks to clear vision, defined values and, above all, our people. Our industry focus helps KPMG firms’ professionals develop a rich understanding of clients' businesses and the insight, skills and resources required to address industry-specific issues and opportunities. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. Each KPMG firm … Sectors: Consulting, audit | 6458 | 5477 | 664 | |
Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: Pharmaceutical | 984 | 700 | 263 | |
Medtronic Engineering the extraordinary A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives. Sectors: Pharmaceutical | 976 | 881 | 27 | |
Prudential Assurance Company Singapore Prudential Assurance Company Singapore, an indirect wholly-owned subsidiary of Prudential plc, is one of Singapore’s leading life insurance companies. We are one of the market leaders in protection, savings and investment-linked plans, with S$53.3 billion funds under management as at 31 December 2023. In testament to our financial strength, we have an ‘AA-‘ financial strength rating from leading credit rating agency Standard & Poor’s. We have been serving the financial needs of Singapore for 93 years, delivering a suite of product offerings and professional advisory through our network of more than 5,200 financial representatives with our tied agency and financial … Sectors: Insurance | 427 | 160 | 194 | |
HTGF | High-Tech Gründerfonds Seed Investor. We invest in People. Venture Capital for High-Tech Founders. Made in Germany. HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more … | 892 | 461 | 506 | |
Apple We’re a diverse collective of thinkers and doers, continually reimagining what’s possible to help us all do what we love in new ways. And the same innovation that goes into our products also applies to our practices — strengthening our commitment to leave the world better than we found it. This is where your work can make a difference in people’s lives. Including your own. Apple is an equal opportunity employer that is committed to inclusion and diversity. Visit apple.com/careers to learn more. Innovative Product Development, World-Class Operations, Retail, and Telephone Support Sectors: Consumer Electronics | 13571 | 10927 | 172 | |
Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: Chemistry Pharmaceutical | 4734 | 2898 | 637 | |
General Electric A new era is here, and we want you to be a part of it. We will now be sharing our content on our respective GE Aerospace and GE Vernova pages. Be sure to follow each to keep up with the future of aviation and energy. Oil & Gas, Healthcare, Intelligent Platforms, Renewable Energy, Transportation, Aviation, Digital, Lighting, Power, and Energy Management Sectors: Building supplies | 4863 | 3071 | 665 | |
Fresenius Medical Care Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We aim to create a future worth living for chronically and critically ill patients – worldwide and every day. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help them to enjoy the very best quality of life. Our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various dialysis treatment options for both in-center and home dialysis that are individually tailored to our patients’ needs. dialysis, hemodialysis, … Tags: DAX30 Sectors: Pharmaceutical | 522 | 309 | 81 | |
Oxford Science Enterprises We found, fund and build transformational businesses via our unique partnership with the University of Oxford Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses across specialist areas of life sciences, health tech, AI, new compute, climate tech and agtech. Via our unique partnership with the University of Oxford, the world's #1 research university, we turn the world's most advanced science and technology into companies tackling the world's toughest challenges. In nine years, we have invested £0.7 billion in over 120 ambitious companies built on Oxford science. A key … Sectors: Startup accelerator & VC | 273 | 102 | 117 | |
Plug and Play Tech Center Driving the future forward with corporations, governments, startups, investors, and universities. Plug and Play is the ultimate innovation platform. Our mission is to build the world’s leading innovation platform and make innovation open to anyone, anywhere. We do this by connecting entrepreneurs, corporations, and investors worldwide. Over the past 15 years, we have brought together 35,000+ startups, 500+ world-leading corporations, and hundreds of venture capital firms, universities, and government agencies across 20+ industries. We are active in 50+ locations globally, including the U.S., China, France, Germany, South Africa, Singapore, Indonesia, Brazil, and more. Together with our partners, we are creating … Sectors: Startup accelerator & VC | 3557 | 1992 | 646 | |
Solvay We are Solvay, mastering the elements essential to our world. Welcome to Solvay, where science and mastery come together, creating excellence that stands the test of time. With a 160-year legacy, we're not just innovators; we're on a constant journey of progress, mastering the essential elements of our world. We're all about revealing potentials, just like you. Recognizing what's crucial for our world, our solutions aim for a sustainable future, making a positive impact on individuals and communities worldwide. In the market, we're leading the way with best-in-class essential chemicals, making a difference in critical sectors like construction, healthcare, consumer … Sectors: Chemistry | 1384 | 798 | 273 | |
IBM At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If you're searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you. We're here to help every creator turn their "what if" into what is. Let's create something that will change everything. Cloud, Mobile, Cognitive, Security, Research, Watson, Analytics, Consulting, Commerce, Experience Design, Internet of Things, Technology support, Industry solutions, Systems services, Resiliency services, Financing, and IT infrastructure Sectors: IT services | 15821 | 10689 | 536 | |
Accenture Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale. We are a talent and innovation-led company serving clients in more than 120 countries. We combine our strength in technology and leadership in cloud, data and AI with unmatched industry experience, functional expertise and global delivery capability. We measure our success by the 360° value we create for our clients, each other, our shareholders, partners and communities. This LinkedIn company page is … Sectors: Consulting, audit | 12853 | 8210 | 1223 | |
CogX Festival CogX's mission is to convene the tech industry, global leaders, changemakers, creatives and policy makers together to address the critical question 'How do we get the next 10 years right?'. We do this through our Festivals and Summits, combining leading speakers, highly focused content sessions and executive networking. Often described as a ‘festival of ideas’ with the heart of a meet up and the polish of Davos, CogX is an opportunity to immerse yourself in all things AI. We are thrilled to be hosting two events in 2024, The Leadership Summit in London on October 7th, and even sooner … | 1037 | 339 | 667 | |
Lever Offering talent leaders the reach of a marketing leader, forecast of a sales leader, and insight of a finance leader. Lever is a leading Talent Acquisition Suite that makes it easy for talent teams to reach their hiring goals and to connect companies with top talent. Lever is the only platform that provides all talent acquisition leaders with complete ATS and robust CRM capabilities in one product, LeverTRM. The Lever Hire and Lever Nurture features allow leaders to scale and grow their people pipeline, build authentic and long-lasting relationships, and source the right people to hire. Lever Analytics provides customized … Sectors: Consumer Goods Food | 6546 | 4319 | 551 |